Floatz logo

Therapeutic Asset Ratings

395 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[²¹²pb]pb-advc001
Prostate Cancer
AdvanCell Pty LimitedP1/2CC (40)
64cu-grip b
Prostate Cancer
Rahul AggarwalP1/2CC (40)
aaa602
Prostate Cancer
Novartis PharmaceuticalsP1/2CC (40)
aaa802
Prostate Cancer
Novartis PharmaceuticalsP1/2CC (40)
Ace-86225106
Prostate Cancer
Acerand Therapeutics (Shanghai) LimitedP1/2CC (40)
Actinium Rhpsma-10.1
Prostate Cancer
University College, LondonP1/2CC (40)
Allogeneic Adipose-Derived Mesenchymal Stem Cells
Prostate Cancer
The Methodist Hospital Research InstituteP1/2CC (40)
AMXI-5001
Prostate Cancer
AtlasMedx, IncorporatedP1/2CC (40)
Apl-5125
Prostate Cancer
Apollo Therapeutics LtdP1/2CC (40)
as1986ns
Prostate Cancer
Antelope Surgical Solutions, IncP1/2CC (40)
azd9750
Prostate Cancer
AstraZenecaP1/2CC (40)
BMS 986253
Prostate Cancer
Mark SteinP1/2CC (40)
Camizestrant
Prostate Cancer
AstraZenecaP1/2CC (40)
Chadox1-Pcaq
Prostate Cancer
Barinthus BiotherapeuticsP1/2CC (40)
coq10
Prostate Cancer
University of NebraskaP1/2CC (40)
Datopotamab Deruxtecan
Prostate Cancer
AstraZenecaP1/2CC (40)
Envafolimab
Prostate Cancer
Tianjin Medical University Second HospitalP1/2CC (40)
Etx-19477
Prostate Cancer
858 Therapeutics, Inc.P1/2CC (40)
Fianlimab
Prostate Cancer
University of Wisconsin, MadisonP1/2CC (40)
Fog-001
Prostate Cancer
Parabilis Medicines, Inc.P1/2CC (40)
for46
Prostate Cancer
Rahul AggarwalP1/2CC (40)
Fractionated Dose Of 225Ac-J591
Prostate Cancer
Weill Medical College of Cornell UniversityP1/2CC (40)
ga-68-ngul
Prostate Cancer
Cellbion Co., Ltd.P1/2CC (40)
her2 fpbmc
Prostate Cancer
University of VirginiaP1/2CC (40)
Hrs-1167
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.P1/2CC (40)
Showing 226 to 250 of 395 assets
PreviousPage 10 of 16Next